Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

UnitedHealth Group Incorporated UNH shares have tumbled 25.4% in the past month alone, bringing their year-to-date loss to 40 ...

The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Human, one of the largest Medicare Advantage insurers in the U.S., recently shared its stance. In a one-page policy overview viewed by The Wall Street Journal, the company favored limiting insurers’ ...

Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE:HUM) and a $313 price target. The ...